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1. Introduction 
HIV and AIDS continues to ravage developing countries especially those in sub-Saharan 
Africa three decades into the pandemic. It has eroded social, political and economic health 
gains and dealing with its consequences is one of the greatest challenges of the new the 
millennium. There has been a decline in life expectancy in adults, an increase in child 
mortality rates that has reversed the years of hard won gains achieved in child survival, 
deepening poverty and exacerbation of food shortages. Susceptibility to HIV AIDS is 
sustained by the lack of economic, social and political influence, including the capability to 
effectively inform decision makers and policymakers. The majority of people affected by 
HIV/AIDS are vulnerable populations who live under conditions of gender-based violence, 
poor access to health care and inadequate living conditions. There is an urgent need for 
strategies to remove the barriers that prevent them from voluntary testing and counselling 
and accessing oral health promotion, prevention and treatment services. 
2. Importance & relevance of oral lesions in HIV/AIDS 
Oral lesions are a common occurrence in individuals with HIV infection. Oral 
manifestations include fungal, viral and bacterial infections. Neoplasms, periodontal 
disease, salivary gland disease and lesions of uncertain origin are also seen. Several studies 
have emphasised the prognostic significance of oral candidiasis and oral hairy leukoplakia 
as predictors of immuno suppression and AIDS-defining conditions. Lesions such as oral 
candidiasis, herpetic ulcers and Kaposi’s sarcoma are among the first symptoms of HIV-
infection. These conditions, although not life-threatening, impact on the quality of life 
(Yengopal & Naidoo, 2008) and are often associated with significant pain, discomfort, eating 
restrictions and consequent diminished nutritional intake. The oral cavity may also be a 
primary source of infection in any individual, which may spread via the mucosal associated 
lymphoid tissue or stimulate systemic inflammatory immune responses (Chapple & 
Hamburger, 2000).   
The treatment and management of oral HIV lesions can considerably improve well being. 
Antiretroviral treatment and improved management of HIV, has been shown to reduce the 
prevalence of oral manifestations, but there may be an increase in oral warts and salivary 
gland disease (Greenspan et al., 2001). Oral examination is quick and inexpensive and may 
have a place, especially in primary health care settings and for screening populations at 
greater risk of HIV. Early detection of HIV-related oral lesions can be used to diagnose HIV 
infection, elucidate progression of the disease, indicate a response to antiretroviral therapy 
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and by predicting immune status can result in timely therapeutic intervention. For HIV 
infection in women it may be useful in ante-natal screening so that appropriate drug 
management can be instituted to reduce vertical transmission.  
3. Oral lesions: Types and management  
3.1 Oral candidiasis 
Oral candidiasis is the most common oral lesion with a variable clinical presentation. 
Candida albicans is the most common cause. It is manifested as creamy white 
pseudomembranous plaques, erythematous patches, non-scrapable hyperplastic plaques or 
as angular chelitis. Once colonisation and super-infection by Candida spp. are established, 
deeper penetration into submucosal tissue may be facilitated by concomitant mucosal 
infections caused by bacteria and herpes simplex virus (HSV). In children, lesions are often 
characteristically of the pseudomembranous and erythematous types. Early presentations 
are often asymptomatic. Candidiasis may be accompanied by pain and an altered taste 
sensation, both of which interfere with nutrition and hydration and may be exacerbated by 
decreased salivary flow. 
Pseudomembranous candidiasis is the most common variant and presents as creamy white 
or yellow, loosely adherent plaques anywhere in the mouth and it can be wiped off to reveal 
an erythematous surface with or without bleeding (Figures 1 and 2). Erythematous 
candidiasis presents as multiple, flat, diffuse or discrete red non-removable plaques. It is 
usually found on the palate, tongue and occasionally on the buccal or labial mucosa (Figure 
3). A variant of erythematous candidiasis is median rhomboid glossitis – presenting as a 
smooth, red, depapilated area in the middle of the tongue (Figure 4).  
 
 
Fig. 1. Pseudomembranous Candidiasis Palate 
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Fig. 2. Pseudomembranous Candidiasis Gingiva (with caries) 
 
 
Fig. 3. Erythematous Candidiasis Palate 
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Fig. 4. Median Rhomboid Glossitis Tongue 
Hyperplastic candidiasis is usually seen on the buccal mucosa as diffuse, white, adherent 
lesions (Figure 5). It needs to be distinguished from oral hairy leukoplakia. 
Angular cheilitis presents as fissures or linear ulcers at the corners of the mouth, with 
varying degrees of inflammatory erythema. Hyperkeratosis may be present peripheral to 
the fissure. Concurrent with angular cheilitis, intraoral candidal involvement is a common 
clinical finding. The lesions are usually painful and slow to heal because of the repeated 
opening of the mouth (Figure 6). 
Management: Candidiasis should be treated promptly and vigorously and early treatment is 
warranted, not only because of discomfort, but also because infection may spread to the 
pharynx and oesophagus. Either topical or systemic antifungal agents may be 
recommended. Topical treatments include 0.5% gentian violet aqueous solution painted in 
the mouth three times daily and nystatin suspension 100 000IU/Ml rinse. In severe cases 
apply 2% micoazole oral gel two or three times daily for ten days and suck amphotericin B 
lozenges 10mg six hourly for ten days. 
Recurrences are common and if there is no response in one or two weeks, systemic agents 
may be required:  Fluconazole 50-100mg daily for seven days, Ketoconazole 200-400mg 
daily for seven days. Itraconazole 200mg daily for seven days may be useful for azole-
resistant C.albicans infection. Angular cheilitis is best managed with topical nystatin or for a 
mixed flora infection miconozole gel.   
Due to the high sugar content of some formulations, topical fluoride should be used daily, if 
frequently prescribed. Dentures should be removed when using medication and local 
contributory risk factors like continuous denture wear, poor denture hygiene and 
xerostomia should be eliminated. 
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Fig. 5. Hyperplastic Candidiasis Buccal mucosa 
 
 
Fig. 6. Angular cheilitis 
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3.2 Oral hairy leukoplakia 
Oral Hairy leukoplakia (OHL) usually presents as white, vertically corrugated projections 
on the lateral borders of the tongue, unilateral or bilateral and cannot be rubbed off (Figure 
7). It is a benign, usually asymptomatic and more common in men. Studies have shown that 
it is associated with intraepithelial proliferation of the human herpesvirus, the Epstein-Barr 
virus (EBV) and that multiple strains for the virus are often present in OHL tissues 
(Ammatuna, 2001). OHL is the only lesions caused by EBV in which the virus replicates and 
is commnly shed in saliva (Sitki-Green et al., 2002).  
 
 
Fig. 7. Oral Hairy Leukoplakia Tongue 
Although it may be a source of concern and discomfort to the patient, specific treatment is 
rarely indicated. Antiretroviral therapy may clear the lesions but the underlying EBV 
infection is rarely eliminated. Aciclovar 800mg three to five times daily for ten days may be 
recommended for patients complaining of discomfort. The presence of oral candidiasis and 
oral hairy leukoplakia in patients receiving antiretroviral medication is indicative of the 
failure of therapy. 
3.3 Oral ulceration 
People with HIV present with oral ulcerations of diverse aetiologies. The ulcers may be 
infectious (viral, bacterial or fungal) or atypical (aphthous or drug-induced) in nature. 
Herpetic stomatitis caused by the herpes simplex virus 1 (HSV) is commonly seen in HIV-
infected patients and has a tendency to recur. Lesions may be seen on the gums, hard palate, 
vermillion border of the lips and adjacent facial skin (Figure 8). Early vesicles soon rupture 
to become painful irregular ulcers. In HIV-infected people, the lesions are chronic, recurrent 
and may progress rapidly to cause extensive mucocutaneous involvement that may persist 
for several weeks and extend into the oesophagus.  
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Fig. 8. Herpes Zoster (healing) 
It is widely believed that herpes zoster infection (HZI) is a reactivation of latent varicella 
zoster virus in the dorsal root ganglia. The occurrence of the secondary form of HZI in HIV 
positive patients, manifests on the skin as localised, disseminated or typical generalised 
zoster and may herald a poor prognosis.  
Aphthous ulcerations can be small or large, single or multiple (minor, major or herpetiform 
types). Minor aphthous ulcers are painful, round, well-circumscribed with a whitish 
covering surrounded by an erythematous halo, usually limited to the non-keratinised 
mucosa of the soft palate, buccal mucosa, tongue or tonsillar area but can occur anywhere in 
the mouth. Herpetiform ulcers are the least common type and are pinpoint, round and with 
a perilesional erythema. They are usually found in batches up to a hundred, appearing on 
nokeratinised mucosa such as the ventral surface of the tongue and soft palate. 
Severe recurrent aphthous ulcers (RAU) may occur in the mouth, oropharynx, and 
oesophagus of untreated HIV/AIDS patients. Aphthous ulcers are deeper than herpetic 
ulcers and have a well-defined edge, unlike herpetic ulcers, which are shallower with an 
irregular border. Preceding vesiculation is characteristic of herpetic lesions. Large lesions are 
progressive, chronic and heal slowly. They often interfere with speech and swallowing and 
may contribute to inadequate oral intake and rapid weight loss. 
Management of oral ulcerations: Early diagnosis and treatment of lesions is important as 
severe, long-standing, painful lesions may interfere with nutrition and hydration. Treatment 
is focused on providing symptomatic relief and adequate pain control is essential - 
paracetamol or paracetamol-codeine with topical 2% viscous lidocaine gel and analgesic 
mouth rinses are helpful.  Herpes simplex lesions often heal spontaneously. A 0.5% gentian 
violet aqueous solution painted in the mouth three times daily or 1% topical povidone-
iodine may be useful for small ulcers. Aciclovir is very useful if administered early – 400mg 
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eight hourly for five days will effectively treat large ulcers. Intravenous foscarnet has been 
used to treat acyclovir-resistant HSV infection. Patients sometimes have prolonged bouts 
and frequent recurrences that are accompanied by severe pain and local tissue destruction. 
Short courses of topical corticosteroids should be tried, but these ulcers may be resistant to 
conventional treatment. Thalidomide has been successful in some cases. Viruses may 
occasionally become resistant and antibiotics may be necessary to limit super-infection. 
Treatment for aphthous ulcerations depends on severity of ulcerations. The ulcers respond 
to topical steroids like triamicinolone acetonide 0.1% in a sodium carboxymethylcellulose 
base given eight hourly. A 0.2% chlorhexidine digluconate mouth rinse two to four times 
daily or 1% topical povidone-iodine may also be useful. For large persistent ulcers 
beclomethasone spray (one or two puffs twice daily on the ulcer), benzydamine 
hydrochloride mouthwash or betamethasone 0.5mg tablets (dissolved in 15mL water) may 
be used as a mouthwash for three minutes daily. For longstanding, intractable ulcers, 
systemic steroids like prednisolone may be used, but it is important to exclude 
cytomegalovirus (CMV) and herpes, as steroids may exacerbate these ulcers. Recurrences 
must be treated aggressively. If ulcers persist despite treatment patients should be referred 
for a biopsy to exclude malignancy or CMV infection.  
3.4 Kaposi's sarcoma 
Kaposi’s sarcoma (KS) is a neoplasm of putative vascular origin. It is a multifocal neoplastic 
proliferation of endothelail cells. Oral lesions of KS lesions are red, blue and purple and 
occur commonly on the posterior hard palate and the facial gingiva (Figure 9), with or 
without ulcerations. Lesions on the palate are associated with pulmonary KS (Pozniak et al., 
1992). The African form is characterised by lymph node enlargement. If untreated, they may 
spread and ulcerate. The human herpes virus 8 (HHV-8) has been identified in all forms of 
KS and its replication in the oral cavity and viral shedding in saliva are important factors for 
HHV-8 transmission (Pauk et al., 2000). Recent research has suggested that in certain in vivo 
conditions, oral micoorganisms like Porphyromonas gingivalis, Fusobacterium nucleatum and 
Prevotella intermedia can potentially activate HHV-8 to cause disease (Morris et al., 2007). 
Lesions begin as flat red macules of variable size and irregular configuration. Although they 
may appear as a focal lesion, typical oral KS lesions are multifocal, with numerous isolated 
and coalescing plaques. Eventually the lesions increase in size to become nodular growths 
and may involve the entire palate (Figure 10).  
Nearly two-thirds of patients with oral KS have pain, discomfort or dysphagia, or complain of 
poor aesthetics and require treatment. In the early stages, the differential diagnosis includes 
pyogenic granuloma and giant cell granuloma. A biopsy is essential for a definitive diagnosis.  
Management: The incidence of oral KS has decreased with the introduction of antiretroviral 
treatment, but remains the most common oral malignancy in people with HIV. Treatment 
decisions are made on the basis of the extent of the disease. The early plaque and macular 
lesions are painless and do not require treatment. Nodular lesions may become unsightly 
and interfere with mastication. Isolated oral lesions can be treated by laser or surgical 
excision. Intralesional injections of 1% vinblastine sulphate can cause lesions to regress, 
however, in some patients it produces pain and may require repeated visits before a 
response is achieved. Systemic chemotherapy is indicated for patients with widespread 
progressive disease. Radiation causes mucositis. Benzydamine hydrochloride may cause 
some relief and is recommended mainly when there are obstructive symptoms. Good oral 
hygiene and plaque control is essential to prevent secondary infection. 
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Fig. 9. Kaposi’s sarcoma palate 
 
 
Fig. 10. Kaposi’s sarcoma ulcerated 
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3.5 Non-Hodgkins lymphoma 
Non-Hodgkins lymphoma (NHL) is the second most common malignant condition 
associated with HIV infection. It comprises a group of malignant lymphoproliferative 
diseases and is an AIDS-defining condition. Lymphomas present as focal soft oral swellings 
with or without ulceration. They may be red and inflamed and are commonly found on the 
gingival, palatal or alveolar mucosa (Cattaneo et al., 2005, Iamaroon et al., 2003).  The lesions 
are painful and may progress rapidly. Lesions must be biopsied for a definitive histological 
diagnosis. Treatment requires systemic combination chemotherapy and occasionally 
radiotherapy. To reduce pain and interference with chewing and speaking, large exophytic 
or pedunculated lesions can be surgically removed. Treatment is almost always palliative. 
For patients with KS and lymphomas, good oral hygiene, plaque control and frequent 
professional cleaning needs to be encouraged to prevent the lesions becoming infected in the 
advanced stages. Patients on chemo- and radiotherapy require regular care and 
maintenance to manage specific oral complications of mucositis and xerostomia and prevent 
the associated increased risks of bacterial and fungal super-infections. Benzydamine 
hydrochloride mouth rinse may provide relief and is recommended when there are 
obstructive symptoms. The immune reconstitution associated with antiretroviral therapy 
may cause lesions to regress.   
4. Gingival and periodontal lesions 
The gingival and periodontal lesions associated with HIV infection include linear gingival 
erythema (LGE), necrotising ulcerative gingivitis (NUG), necrotising ulcerative periodontitis 
(NUP) and nectrotising stomatitis. Linear gingival erythema is characterized by a profound 
erythema of the gingival margin especially of the front teeth (Figure 11). In necrotizing 
ulcerative gingivitis there is destruction of one or more interdental papillae with bleeding, 
ulceration, necrosis and sloughing. Tissue destruction is limited to the gingival tissues and 
does not involve the alveolar bone. Necrotising ulcerative periodontitis is characterized by 
advanced necrotic destruction of the periodontium. There is rapid loss of the periodontal 
attachment, destruction and sequestration of bone and teeth may become mobile. It is often 
accompanied by severe pain and halitosis.  
Several herpesvirus have been shown to be involved in periodontal disease, particularly 
human cytomegalovirus and EBV (Slots, 2000) - the latter being associated with destructive 
periodontal disease. Herpesviruses were shown to be positively associated with elevated 
levels of periodontopathic bacteria (Slots, 2007).  
Management is based on plaque reduction and includes thorough curettage and 
debridement. Strict oral hygiene measures to be prescribed including meticulous brushing 
and flossing. A dental referral for professional scaling, local debridement, followed by 
sub-gingival irrigation and regular long-term maintenance is indicated. Mouth rinses and 
antibiotic therapy may also be indicated. A regimen of topical antiseptic agents such as 
1% povidone-iodine solution and 0.2% chlorhexidine gluconate mouth rinse two or four 
times daily is often initiated as an adjunct therapy. This regimen should be continued 
until all the diseased hard and soft tissue has been removed and the patient is no longer 
symptomatic. 
In severe cases, topical antimicrobial treatment should be supplemented by a short course of 
systemic antimicrobial therapy. Metronidazole 400mg 8 hourly for 5 days may be prescribed 
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for necrotising lesions. Clindamycin 300mg eight hourly for 7-14 days or co-amoxiclav 
375mg eight hourly for five days may be used as alternatives. Mobile teeth may need to be 
splinted or extracted. Bony sequestrations should be removed under antibiotic cover. 
 
 
Fig. 11. Linear gingival erythema 
5. Salivary Gland Disease (SGD) 
Several salivary gland disorders are found in patients with HIV. Parotid gland enlargement 
often accompanies a syndrome of persistent generalized lymphadenopathy caused by 
lymphoid proliferation in response to HIV - a condition known as diffuse infiltrative 
lymphocytosis syndrome (DILS). Patients will DILS are at high-risk of developing 
lymphoma (Harris, 1999). It is associated with slow progression of the disease. 
Antiretroviral medication has decreased the prevalence of SGD in adults, but not in 
children. Parotid gland enlargement may manifest as a unilateral (Figure 12) or bilateral 
swelling (Figure 13) that may fluctuate in size but commonly persists. Recurrent bacterial 
parotitis may occur. Salivary gland disease is usually associated with reduced salivary flow 
and persistent dry mouth and may predispose to the development of dental caries. 
Management: No definite treatment is indicated for HIV-related salivary gland disease if 
there is no super-infection. Oral broad spectrum antibiotics should be used in the treatment 
of suspected bacterial salivary gland infection. Dry mouth should be treated with salivary 
substitutes containing methylcellulose. Glycerine may be useful. Sugarless chewing gum 
should be recommended to stimulate salivary flow. A dry mouth can predispose a patient to 
dental caries, therefore thorough oral hygiene and the daily use of topical fluoride rinses, 
varnishes or gels should be recommended to prevent caries. The intake of sugar and sugary 
foods should be limited. 
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Fig. 12. Parotid gland swelling (adult) 
 
 
Fig. 13. Parotid gland swelling (child) 
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6. HPV infection and oral warts 
Infections with human papilloma virus (HPV) have distinct appearances and a specific 
expression of an identified HPV genotype. A few HPV subtypes have been implicated with 
a subset of oral cancers due to their high-risk oncogenic potential (Nokta, 2008). Most cases 
of HPV-related oropharyngeal cancers (OPC) are caused by HPV-16 (D’Souza et al 2007) 
and occurs at higher rates in men who are HIV positive. HPV is particularly associated with 
head and neck squamous cell carcinomas of the lingual and palatine tonsils. Furthermore, 
the prevalence of HPV infection in the oral cavity of HIV-positive people without oral 
cancer was higher than those who were HIV-negative and was strongly associated with HIV 
infection, immuno-suppression and oro-genital contact (Kreimer et al., 2008). 
The increasing prevalence of benign oral warts that has been found in patients on 
antiretroviral therapy has been associated with HPV-13 and HPV-32 (Greenspan et al., 
2001).This was initially thought to be part of the immune reconstitution syndrome, but Lilly 
et al (2005) reported that the pathology of oral warts was independent of immune 
reconstitution. Warts are proliferative epithelial lesions and can be found anywhere in the 
mouth or lips and are cauliflower-like, spiked or raised with a flat surface. Most lesions are 
asymptomatic, but can interfere with mastication and raise cosmetic concerns. Treatment 
includes surgical excision, cryotherapy, laser ablation and topical application of 
keratinolytic agents, but they do tend to recur.  
7. Oral health & HIV in children 
The oral manifestations of AIDS in children are different from that of adults and can affect 
them more severely. Studies have emphasised the prognostic significance of oral hairy 
leukoplakia, Kaposi’s sarcoma and Non-Hodgkin’s lymphoma as AIDS-defining conditions 
in adults. Oral candidiasis, parotid gland enlargement, recurrent oral ulcerations and 
gingival and periodontal disease are the most prevalent oral manifestations commonly seen 
in children with AIDS.  
Molluscum contagiosum is commonly seen on the face. It is caused by the poxvirus that 
infects the skin and is characterized by clusters of variable sized pearly-white smooth 
papules, showing characteristic central umbilication. It is usually self-limiting, but in 
severely immunosuppressed children may be extensive and disfiguring (Figure 14). 
Management is difficult but repeated topical applications of potassium hydroxide, silver 
nitrate, liquid nitrogen may be helpful. Dental manifestations include and increased 
prevalence in dental caries (Naidoo & Chikte, 2004), delayed eruption (Hauk et al., 2001) 
and over-retention of primary teeth (Flaitz et al., 2001). Children with decreased salivary 
flow and xerostomia should maintain thorough oral hygiene and use topical fluorides 
(rinses, gels and varnishes) to prevent caries. Dietary control is essential to limit the intake of 
sugar and sugary foods. Sugar-based medication should be avoided. 
8. Oral lesions in resource poor settings 
Many patients may present with any of the lesions described above that are suggestive, but 
not diagnostic of HIV infection. In resource-poor settings definitive diagnosis may be 
problematic due to lack of sophisticated diagnostic tests. While oral lesions, may serve as 
useful indicators not only for disease progression in untreated HIV-positive patients, or 
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herald failure of treatment in those receiving antiretroviral agents, it should not replace 
traditional tests for viral loads, CD4 counts and other pathological measurements for 
positive confirmation.  
 
 
Fig. 14. Molluscum Contagiosum 
Saliva has been shown to contain a variety of factors that protects against HIV infection 
including mucins, secretory leukocyte protease inhibitor, salivary agglutinin, defensins and 
secretory IgA. Mucosal IgA has been shown to exert antiviral activity by direct 
neutralization, blocking HIV attachment to epithelial or other target cell receptors and 
transcytosis of HIV across epithelial cells (Challacombe & Naglik, 2006; Kazmi et al., 2006; 
Weinberg et al., 2006). Collection of saliva is simple and non-invasive and in resource-poor 
settings or for large scale population screening, salivary tests may be used to determine HIV 
serostatus (Chen et al., 2007). More recently, the oral cavity has been viewed as a potentially 
useful site to initiate a vaccine induced oral mucosal immune response and it is thought that 
oral mucosal vaccines may induce cellular and humoral immune responses similar to 
systemic immunization (Stahl-Henning et al 2007). 
9. Concluding remarks 
Oral health care workers can contribute to the early diagnosis, prevention and treatment of 
HIV. The oral health management of HIV infected patients should focus on the provision of 
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dental care and treatment of the oral manifestations of the disease. Despite the fact that 
significant advances in the pathogenesis and management of the oral manifestations of HIV 
have been made, more research is required to elucidate the long-term effects of 
antiretroviral therapy, HPV involvement, the progression and significance of SGD and 
creative, innovative strategies to reduce the barriers of vulnerable populations seeking oral 
and general health care. 
The health care worker would need to ascertain the patient’s overall health status, immune 
status, prognosis, presence and history of opportunistic infections, risk for developing more 
serious opportunistic infections, current medications and their long-term survival. Usually 
no dental modifications are required for patients based on their HIV status. HIV-positive 
patients should always receive treatment which is standard in its substance (i.e. the same 
treatment which would be administered to HIV-negative patients) though the treatment 
may be non-standard in its manner (e.g. slower, more careful treatment, involving greater 
protective measures). Major concerns are impaired haemostatis, susceptibility to infections, 
drug interactions and the patient’s ability to withstand the stress and trauma of the dental 
procedure. Treatment planning for HIV-positive patients needs to be carefully thought 
through and address numerous considerations. 
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